Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Nov 28, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Nov 28, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, company-update
Related Tickers: HUGE
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K, confirming 20-F annual report submission. All good.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on November 28, 2025, reporting for the month of November 2025. The company, incorporated in A6 with its principal executive office in Toronto, Ontario, is a pharmaceutical preparations company. This filing indicates they are submitting their annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status and confirms their adherence to SEC regulations for foreign private issuers, which is crucial for investor transparency.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new material events or financial changes.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- November 2025 (date) — Reporting period for the 6-K
- November 28, 2025 (date) — Filing date of the 6-K
- Toronto, Ontario (location) — Location of principal executive office
- Form 20-F (document) — Annual report form to be filed
- Form 6-K (document) — Type of filing submitted
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of November 2025 and to indicate that the registrant files its annual reports under cover of Form 20-F.
What was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc.
When was the company's name changed?
The date of the name change from FSD Pharma Inc. to Quantum Biopharma Ltd. was March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
Quantum Biopharma Ltd.'s principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario, M5C 2V9.
Does Quantum Biopharma Ltd. file its annual reports as a Form 20-F or Form 40-F?
Quantum Biopharma Ltd. files its annual reports under cover of Form 20-F, as indicated by the checkmark in the filing.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-11-28 08:25:26
Filing Documents
- f6k_112825.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-007645.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: November 27, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated November 27, 2025